145 related articles for article (PubMed ID: 10074912)
1. No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11.
Luostarinen T; af Geijersstam V; Bjørge T; Eklund C; Hakama M; Hakulinen T; Jellum E; Koskela P; Paavonen J; Pukkala E; Schiller JT; Thoresen S; Youngman LD; Dillner J; Lehtinen M
Int J Cancer; 1999 Mar; 80(6):818-22. PubMed ID: 10074912
[TBL] [Abstract][Full Text] [Related]
2. Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries).
Hakama M; Luostarinen T; Hallmans G; Jellum E; Koskela P; Lehtinen M; Thoresen S; Youngman L; Hakulinen T
Cancer Causes Control; 2000 Oct; 11(9):783-90. PubMed ID: 11075866
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas.
Sigstad E; Lie AK; Luostarinen T; Dillner J; Jellum E; Lehtinen M; Thoresen S; Abeler V
Br J Cancer; 2002 Jul; 87(2):175-80. PubMed ID: 12107839
[TBL] [Abstract][Full Text] [Related]
4. Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri.
Luostarinen T; Lehtinen M; Bjørge T; Abeler V; Hakama M; Hallmans G; Jellum E; Koskela P; Lenner P; Lie AK; Paavonen J; Pukkala E; Saikku P; Sigstad E; Thoresen S; Youngman LD; Dillner J; Hakulinen T
Eur J Cancer; 2004 May; 40(7):1058-65. PubMed ID: 15093583
[TBL] [Abstract][Full Text] [Related]
5. Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer.
Arnheim Dahlström L; Andersson K; Luostarinen T; Thoresen S; Ögmundsdottír H; Tryggvadottír L; Wiklund F; Skare GB; Eklund C; Sjölin K; Jellum E; Koskela P; Wadell G; Lehtinen M; Dillner J
Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2541-50. PubMed ID: 21994401
[TBL] [Abstract][Full Text] [Related]
6. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer.
Koskela P; Anttila T; Bjørge T; Brunsvig A; Dillner J; Hakama M; Hakulinen T; Jellum E; Lehtinen M; Lenner P; Luostarinen T; Pukkala E; Saikku P; Thoresen S; Youngman L; Paavonen J
Int J Cancer; 2000 Jan; 85(1):35-9. PubMed ID: 10585579
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
[TBL] [Abstract][Full Text] [Related]
8. Order of HPV/Chlamydia infections and cervical high-grade precancer risk: a case-cohort study.
Luostarinen T; Namujju PB; Merikukka M; Dillner J; Hakulinen T; Koskela P; Paavonen J; Surcel HM; Lehtinen M
Int J Cancer; 2013 Oct; 133(7):1756-9. PubMed ID: 23526412
[TBL] [Abstract][Full Text] [Related]
9. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer.
Dillner J; Lehtinen M; Björge T; Luostarinen T; Youngman L; Jellum E; Koskela P; Gislefoss RE; Hallmans G; Paavonen J; Sapp M; Schiller JT; Hakulinen T; Thoresen S; Hakama M
J Natl Cancer Inst; 1997 Sep; 89(17):1293-9. PubMed ID: 9293920
[TBL] [Abstract][Full Text] [Related]
10. Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland.
Laukkanen P; Koskela P; Pukkala E; Dillner J; Läärä E; Knekt P; Lehtinen M
J Gen Virol; 2003 Aug; 84(Pt 8):2105-2109. PubMed ID: 12867641
[TBL] [Abstract][Full Text] [Related]
11. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix.
Burk RD; Terai M; Gravitt PE; Brinton LA; Kurman RJ; Barnes WA; Greenberg MD; Hadjimichael OC; Fu L; McGowan L; Mortel R; Schwartz PE; Hildesheim A
Cancer Res; 2003 Nov; 63(21):7215-20. PubMed ID: 14612516
[TBL] [Abstract][Full Text] [Related]
12. Trends over time in the incidence of cervical neoplasia in comparison to trends over time in human papillomavirus infection.
Dillner J
J Clin Virol; 2000 Oct; 19(1-2):7-23. PubMed ID: 11091144
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus infection and cervical cancer in Brazil: a retrospective study.
Cavalcanti SM; Deus FC; Zardo LG; Frugulhetti IC; Oliveira LH
Mem Inst Oswaldo Cruz; 1996; 91(4):433-40. PubMed ID: 9070405
[TBL] [Abstract][Full Text] [Related]
14. Annual disease burden due to human papillomavirus 16 and 18 infections in Finland.
Syrjänen KJ
Scand J Infect Dis Suppl; 2009; 108():2-32. PubMed ID: 19939209
[TBL] [Abstract][Full Text] [Related]
15. Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer.
Combita AL; Bravo MM; Touzé A; Orozco O; Coursaget P
Int J Cancer; 2002 Feb; 97(6):796-803. PubMed ID: 11857357
[TBL] [Abstract][Full Text] [Related]
16. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma.
Anttila T; Saikku P; Koskela P; Bloigu A; Dillner J; Ikäheimo I; Jellum E; Lehtinen M; Lenner P; Hakulinen T; Närvänen A; Pukkala E; Thoresen S; Youngman L; Paavonen J
JAMA; 2001 Jan; 285(1):47-51. PubMed ID: 11150108
[TBL] [Abstract][Full Text] [Related]
17. Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks.
Kapeu AS; Luostarinen T; Jellum E; Dillner J; Hakama M; Koskela P; Lenner P; Löve A; Mahlamaki E; Thoresen S; Tryggvadóttir L; Wadell G; Youngman L; Lehtinen M
Am J Epidemiol; 2009 Feb; 169(4):480-8. PubMed ID: 19074773
[TBL] [Abstract][Full Text] [Related]
18. Seroepidemiology of human papillomavirus type 73: a sexually transmitted low-risk virus.
Wallin KL; van Doornum GJ; Andersson-Ellström A; Kallings I; Wiklund F; Hallmans G; Schiller J; Dillner J
Int J Cancer; 2000 Feb; 85(3):353-7. PubMed ID: 10652426
[TBL] [Abstract][Full Text] [Related]
19. Risk of seropositivity to multiple oncogenic human papillomavirus types among human immunodeficiency virus-positive and -negative Ugandan women.
Namujju PB; Waterboer T; Banura C; Muwonge R; Mbidde EK; Byaruhanga R; Muwanga M; Surcel HM; Pawlita M; Lehtinen M
J Gen Virol; 2011 Dec; 92(Pt 12):2776-2783. PubMed ID: 21832008
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer.
Smith JS; Herrero R; Bosetti C; Muñoz N; Bosch FX; Eluf-Neto J; Castellsagué X; Meijer CJ; Van den Brule AJ; Franceschi S; Ashley R;
J Natl Cancer Inst; 2002 Nov; 94(21):1604-13. PubMed ID: 12419786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
